University of Annunzio
New findings in diabetes therapy described
Published in Fitness and Wellness Business Week, May 11th, 2005
Study 1: Early metformin treatment is an evidence-based strategy that reduces the burden of late-developing diabetes complications in patients with type 2 diabetes.
"A major aim of glucose-lowering therapy in people with diabetes is to delay or prevent the late-developing complications of diabetes that threaten the quality and duration of life. While intensive interventions to control hyperglycemia may impair well-being to some extent, the balance of quality of life is usually highly positive. Diet and exercise therapy remains the cornerstone of management, and should...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week
More Articles from Fitness and Wellness Business Week
- iVOW, Inc.
Obesity-focused company announces form 10-K going concern inclusion in report - Palatin Technologies, Inc.
Data from preclinical evaluation of PT-15 for obesity treatment presented - WellGen, Inc.
Biotechnology company announces addition of 4 members to management team - American Heart Association
Early prevention of weight gain offers best solution - Australian National University
Mutations linked to chloroquine resistance lower Plasmodium fitness - Australian National University
Studies describe new findings in insulin resistance research - More from this issue of Fitness and Wellness Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
